283 related articles for article (PubMed ID: 21146391)
1. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
Ong DS; Kelly JW
Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
Tao YX; Conn PM
Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
[TBL] [Abstract][Full Text] [Related]
5. Proteostasis: bad news and good news from the endoplasmic reticulum.
Noack J; Brambilla Pisoni G; Molinari M
Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational Diseases.
Kelly JW
Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31088828
[TBL] [Abstract][Full Text] [Related]
7. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
[TBL] [Abstract][Full Text] [Related]
8. Biological and chemical approaches to diseases of proteostasis deficiency.
Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
[TBL] [Abstract][Full Text] [Related]
9. Protein Misfolding Diseases and Therapeutic Approaches.
Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
[TBL] [Abstract][Full Text] [Related]
10. Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.
Pey AL
Amino Acids; 2013 Dec; 45(6):1331-41. PubMed ID: 24178766
[TBL] [Abstract][Full Text] [Related]
11. Mapping and Exploring the Collagen-I Proteostasis Network.
DiChiara AS; Taylor RJ; Wong MY; Doan ND; Rosario AM; Shoulders MD
ACS Chem Biol; 2016 May; 11(5):1408-21. PubMed ID: 26848503
[TBL] [Abstract][Full Text] [Related]
12. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
Iram A; Naeem A
Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding in the endoplasmic reticulum as a conduit to human disease.
Wang M; Kaufman RJ
Nature; 2016 Jan; 529(7586):326-35. PubMed ID: 26791723
[TBL] [Abstract][Full Text] [Related]
14. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
15. An adaptable standard for protein export from the endoplasmic reticulum.
Wiseman RL; Powers ET; Buxbaum JN; Kelly JW; Balch WE
Cell; 2007 Nov; 131(4):809-21. PubMed ID: 18022373
[TBL] [Abstract][Full Text] [Related]
16. A model of threshold behavior reveals rescue mechanisms of bystander proteins in conformational diseases.
Sandefur CI; Schnell S
Biophys J; 2011 Apr; 100(8):1864-73. PubMed ID: 21504722
[TBL] [Abstract][Full Text] [Related]
17. A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.
Baranczak A; Kelly JW
Curr Opin Chem Biol; 2016 Jun; 32():10-21. PubMed ID: 26859714
[TBL] [Abstract][Full Text] [Related]
18. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
Bouchecareilh M; Conkright JJ; Balch WE
Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
[TBL] [Abstract][Full Text] [Related]
19. A review on protein misfolding, aggregation and strategies to prevent related ailments.
Shamsi TN; Athar T; Parveen R; Fatima S
Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
[TBL] [Abstract][Full Text] [Related]
20. Using pharmacological chaperones to restore proteostasis.
Wang YJ; Di XJ; Mu TW
Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
